Chemical Structure (Gabapentin 01)
Gabapentin Tablet
Product Images NDC 71205-774
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-774). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapentin 02)
The text describes pain score data from a study with a dose titration period and a fixed dose period, comparing a placebo group to a group taking 3600 mg/day of Gabapentin. The only specific information provided is a mean pain score of 10 at an unspecified time point.*
Figure 2 (Gabapentin 03)
This is a graph showing the mean pain score of participants over a period of 7 weeks during a study that involved a 4-week fixed dose period. Two groups of participants were given either a placebo or Gabapentin at two different doses (1800 mg/day and 2400 mg/day). The x-axis represents the different weeks and the y-axis represents the mean pain score.*
Figure 3 (Gabapentin 04)
The text contains a graph showing the proportion of responders in controlled studies for the treatment of PHN (post-herpetic neuralgia) with two different medical studies referenced as "Study" and "Study 2". There are percentages listed for each study, but the context and content of the data presented cannot be fully understood without additional information.*
Figure 4 (Gabapentin 05)
71205-774-90 (Gabapentin 07)
This is a description of a Gabapentin medication available in a package of 90 tablets of 800mg each, with NDC number 71205-774-90. The medicine is packaged by Proficient Rx LP from Thousand Oaks, CA. The medication is white to off-white and has a modified capsule shape. Each tablet is film-coated and contains gabapentin, USP. The medication should be kept out of the reach of children and a medication guide should be provided to patients upon dispensing. The product ID is QG077490 and it is manufactured by ScieGen Pharmaceuticals, Inc. from Hauppauge, NY, with lot number 00000 and expiry date of 00/00/00.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
